173 related articles for article (PubMed ID: 15306702)
1. Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response.
dos Santos FB; Miagostovich MP; Nogueira RM; Schatzmayr HG; Riley LW; Harris E
Am J Trop Med Hyg; 2004 Aug; 71(2):144-52. PubMed ID: 15306702
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies.
Simmons M; Porter KR; Escamilla J; Graham R; Watts DM; Eckels KH; Hayes CG
Am J Trop Med Hyg; 1998 Feb; 58(2):144-51. PubMed ID: 9502595
[TBL] [Abstract][Full Text] [Related]
3. Recombinant multiepitope protein for early detection of dengue infections.
Anandarao R; Swaminathan S; Fernando S; Jana AM; Khanna N
Clin Vaccine Immunol; 2006 Jan; 13(1):59-67. PubMed ID: 16426001
[TBL] [Abstract][Full Text] [Related]
4. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent.
AnandaRao R; Swaminathan S; Fernando S; Jana AM; Khanna N
Protein Expr Purif; 2005 May; 41(1):136-47. PubMed ID: 15802231
[TBL] [Abstract][Full Text] [Related]
5. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S; Pilankatta R; Khanna N; Swaminathan S
Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen.
Batra G; Talha SM; Nemani SK; Dhar N; Swaminathan S; Khanna N
Protein Expr Purif; 2010 Nov; 74(1):99-105. PubMed ID: 20435144
[TBL] [Abstract][Full Text] [Related]
7. Recombinant envelope protein-based enzyme immunoassay for IgG antibodies is comparable to neutralization tests for epidemiological studies of dengue infection.
Rocha ES; Oliveira JG; Santos JR; Rodrigues GO; Figueiredo LB; Pessanha JE; Proietti FA; Fonseca FG; Bonjardim CA; Ferreira PC; Kroon EG
J Virol Methods; 2013 Jan; 187(1):114-20. PubMed ID: 23018061
[TBL] [Abstract][Full Text] [Related]
8. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
Chang SF; Huang JH; Chen LK; Su CL; Liao TL; Chien LJ; Lin TH; Su CJ; Shu PY
J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
[TBL] [Abstract][Full Text] [Related]
9. High-level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen.
Huang JL; Huang JH; Shyu RH; Teng CW; Lin YL; Kuo MD; Yao CW; Shaio MF
J Med Virol; 2001 Nov; 65(3):553-60. PubMed ID: 11596093
[TBL] [Abstract][Full Text] [Related]
10. Dengue-1 envelope protein domain III produced in Pichia pastoris: potential use for serological diagnosis.
Cardoso SA; Paixão VF; Oliveira MD; Honda ER; Oliveira LL; da Silva CC; De Paula SO
Protein Expr Purif; 2013 Nov; 92(1):9-13. PubMed ID: 23993978
[TBL] [Abstract][Full Text] [Related]
11. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
Kuruvilla JG; Troyer RM; Devi S; Akkina R
Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
[TBL] [Abstract][Full Text] [Related]
12. [Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection].
Lu P; Wei Y; Cao SC; Li JD; Liu QZ; Zhang QF; Li C; Miao F; Zhang S; Hang XT; Liang MF; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):177-9. PubMed ID: 19031695
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.
Holmes DA; Purdy DE; Chao DY; Noga AJ; Chang GJ
J Clin Microbiol; 2005 Jul; 43(7):3227-36. PubMed ID: 16000440
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of recombinant dengue virus type 4 envelope domain III protein.
Tripathi NK; Babu JP; Shrivastva A; Parida M; Jana AM; Rao PV
J Biotechnol; 2008 Apr; 134(3-4):278-86. PubMed ID: 18342971
[TBL] [Abstract][Full Text] [Related]
16. Design and heterologous expression of dengue virus envelope protein (E) peptides and their use for serological diagnosis.
Honda ER; Zanchi F; Rios K; Lira E; DeusileneVieira ; da Silva LH; De Paula SO
J Virol Methods; 2012 Dec; 186(1-2):55-61. PubMed ID: 22981980
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of dengue NS1 antigen detection tests with acute sera from patients infected with dengue virus in Venezuela.
Ramirez AH; Moros Z; Comach G; Zambrano J; Bravo L; Pinto B; Vielma S; Cardier J; Liprandi F
Diagn Microbiol Infect Dis; 2009 Nov; 65(3):247-53. PubMed ID: 19733994
[TBL] [Abstract][Full Text] [Related]
18. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
[TBL] [Abstract][Full Text] [Related]
19. Detection of dengue virus.
Tripathi NK; Shrivastava A; Dash PK; Jana AM
Methods Mol Biol; 2011; 665():51-64. PubMed ID: 21116795
[TBL] [Abstract][Full Text] [Related]
20. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
